Russell A. Hammond - Concepedia

Author

Russell A. Hammond

Celldex Therapeutics (United States)

Also Known As

R A Hammond, R. Hammond, Russell A. Hammond, Russell Hammond

Publications

859

Citations

H-Index

Concepts

All Affiliations

Celldex Therapeutics (United States)University of Massachusetts Chan Medical School Oncotherapeutics (United States)

About

Russell A. Hammond is an author at Celldex Therapeutics (United States) specializing in medicine, molecular biology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	286
2	Natural Sciences	5	5	150
3	Immunology	5	5	235
4	Cell Biology	3	3	163
5	Allergy	1	1	33

Russell A. Hammond

Publications

825

Citations

H-Index

Page 1

	Year	Citations
Vaccine-Induced Antibodies Inhibit CETP Activity In Vivo and Reduce Aortic Lesions in a Rabbit Model of Atherosclerosis Charles W. Rittershaus, David P. Miller, Lawrence J. Thomas, Arteriosclerosis Thrombosis and Vascular Biology	2000	311
Soluble CR1 Therapy Improves Complement Regulation in C3 Glomerulopathy Yuzhou Zhang, Carla Nester, Danniele G. Holanda, Journal of the American Society of Nephrology Glomerular DiseaseImmunologyPathologyComplement ActivityC3 Glomerulopathy	2013	87
Identification of DNA polymerase .delta. in CV-1 cells: studies implicating both DNA polymerase .delta. and DNA polymerase .alpha. in DNA replication Russell A. Hammond, John Byrnes, Michael R. Miller Biochemistry	1987	73
Effect of DNA polymerase inhibitors on DNA repair in intact and permeable human fibroblasts: evidence that DNA polymerases .delta. and .beta. are involved in DNA repair synthesis induced by N-methyl-N'-nitro-N-nitrosoguanidine Russell A. Hammond, J. Keith McClung, Michael R. Miller Biochemistry	1990	61
A microinjected monoclonal antibody against human DNA polymerase-alpha inhibits DNA replication in human, hamster, and mouse cell lines. Leszek Kaczmarek, Michael R. Miller, Russell A. Hammond, Journal of Biological Chemistry ImmunologyDna AnalysisMolecular BiologyImmunophenotypingImmunotherapy	1986	47
Development of a Novel Antibody–Drug Conjugate for the Potential Treatment of Ovarian, Lung, and Renal Cell Carcinoma Expressing TIM-1 Lawrence J. Thomas, Laura Vitale, Thomas J. O’Neill, Molecular Cancer Therapeutics	2016	42
The Partly Folded Back Solution Structure Arrangement of the 30 SCR Domains in Human Complement Receptor Type 1 (CR1) Permits Access to its C3b and C4b Ligands Patricia B. Furtado, Chen Y. Huang, Demvihin Ihyembe, Journal of Molecular Biology Molecular ImmunologyComplement SystemSignal TransductionImmunologyReceptor (Biochemistry)	2007	39
Bacillus subtilis DNA polymerase III: complete sequence, overexpression, and characterization of the polC gene Russell A. Hammond, Marjorie H. Barnes, Susan L. Mack, Gene Natural SciencesBacteriologyMolecular BiologyDna ReplicationMolecular Genetics	1991	36
Localization of the exonuclease and polymerase domains of Bacillus subtilis DNA polymerase III Marjorie H. Barnes, Russell A. Hammond, Christopher C. Kennedy, Gene Natural SciencesBacteriologyMolecular BiologyDna ReplicationPolymerase Domains	1992	34
Co-administration of a CpG adjuvant (VaxImmuneTM, CPG 7909) with CETP vaccines increased immunogenicity in rabbits and mice Lawrence J. Thomas, Russell A. Hammond, Eric M. Forsberg, Human Vaccines ImmunologyAntigen ProcessingImmunotherapeuticsImmunotherapyCetp Vaccines	2009	33

Page 1